Walker Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
2,964
+20
+0.7% +$2.34K 0.19% 103
2026
Q1
$354K Buy
2,944
+85
+3% +$9.81K 0.19% 102
2025
Q4
$301K Buy
2,859
+24
+0.8% +$2.25K 0.16% 110
2025
Q3
$238K Sell
2,835
-74
-3% -$6.09K 0.13% 117
2025
Q2
$230K Buy
2,909
+120
+4% +$9.54K 0.13% 122
2025
Q1
$250K Buy
2,789
+54
+2% +$5.04K 0.15% 118
2024
Q4
$272K Buy
2,735
+118
+5% +$12.2K 0.17% 107
2024
Q3
$297K Sell
2,617
-55
-2% -$6.53K 0.18% 98
2024
Q2
$331K Sell
2,672
-25
-0.9% -$3.22K 0.22% 86
2024
Q1
$356K Buy
2,697
+16
+0.6% +$1.97K 0.24% 80
2023
Q4
$292K Buy
+2,681
New +$278K 0.21% 93

Other funds holding MRK

Walker Asset Management's MRK Position: Q2 2026 in Review

Walker Asset Management increased its Merck (MRK) stake by 0.68% in Q2 2026, buying an estimated $2.34K and bringing the position to 2,964 shares worth $381K. The position accounts for 0.19% of the portfolio, ranked #103.

Walker Asset Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Walker Asset Management held 2,964 shares of Merck worth $381K as of Q2 2026.
  • Walker Asset Management bought 20 Merck shares in Q2 2026, an estimated $2.34K.
  • Merck made up 0.19% of Walker Asset Management's portfolio in Q2 2026, its #103 holding.
  • Walker Asset Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.